Tyra Biosciences annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Tyra Biosciences Capital Expenditures (CapEx) Growth & History (TYRA)
Tyra Biosciences's capital expenditures (capex) was $141,000 for fiscal 2025.
View full Tyra Biosciences company overviewTyra Biosciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $141,000 | −$523,000 | −78.77% |
| 2024 | 2024-12-31 | $664,000 | −$106,000 | −13.77% |
| 2023 | 2023-12-31 | $770,000 | $211,000 | +37.75% |
| 2022 | 2022-12-31 | $559,000 | −$102,000 | −15.43% |
| 2021 | 2021-12-31 | $661,000 | $349,000 | +111.86% |
| 2020 | 2020-12-31 | $312,000 | — | — |
Tyra Biosciences quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $66,000 | $35,000 | +112.90% |
| Q1 2026 | 2026-03-31 | $88,000 | $74,000 | +528.57% |
| Q4 2025 | 2025-12-31 | $57,000 | $51,000 | +850.00% |
| Q3 2025 | 2025-09-30 | $39,000 | −$13,000 | −25.00% |
| Q2 2025 | 2025-06-30 | $31,000 | −$439,000 | −93.40% |
| Q1 2025 | 2025-03-31 | $14,000 | −$122,000 | −89.71% |
| Q4 2024 | 2024-12-31 | $6,000 | −$597,000 | −99.00% |
| Q3 2024 | 2024-09-30 | $52,000 | −$31,000 | −37.35% |
| Q2 2024 | 2024-06-30 | $470,000 | $427,000 | +993.02% |
| Q1 2024 | 2024-03-31 | $136,000 | $95,000 | +231.71% |
| Q4 2023 | 2023-12-31 | $603,000 | $582,000 | +2771.43% |
| Q3 2023 | 2023-09-30 | $83,000 | $35,000 | +72.92% |
| Q2 2023 | 2023-06-30 | $43,000 | −$208,000 | −82.87% |
| Q1 2023 | 2023-03-31 | $41,000 | −$198,000 | −82.85% |
| Q4 2022 | 2022-12-31 | $21,000 | −$84,000 | −80.00% |
| Q3 2022 | 2022-09-30 | $48,000 | −$208,000 | −81.25% |
| Q2 2022 | 2022-06-30 | $251,000 | $11,000 | +4.58% |
| Q1 2022 | 2022-03-31 | $239,000 | $179,000 | +298.33% |
| Q4 2021 | 2021-12-31 | $105,000 | — | — |
| Q3 2021 | 2021-09-30 | $256,000 | — | — |
| Q2 2021 | 2021-06-30 | $240,000 | — | — |
| Q1 2021 | 2021-03-31 | $60,000 | — | — |
Tyra Biosciences capital expenditures (capex) trends
Over the last five fiscal years, Tyra Biosciences's capital expenditures (capex) decreased from $312,000 to $141,000, a change of −$171,000. The latest reported quarter, Q2 2026, shows $66,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tyra Biosciences source filings ↗